https://stock.noler.com/us/stock/mersana-therapeutics-inc https://stock.noler.com/us/stock/mersana-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/mersana-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/mersana-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/mersana-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/mersana-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/mersana-therapeutics-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/mersana-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/mersana-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/mersana-therapeutics-inc/aoci https://stock.noler.com/us/stock/mersana-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/mersana-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-allowance-for-credit-loss https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-allowance-for-credit-loss-change https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-amortized-cost-allowance-for-credit-loss-excluding-accrued-interest https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-amortized-cost-excluding-accrued-interest-after-allowance-for-credit-loss https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-excluding-accrued-interest https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-excluding-accrued-interest-allowance-for-credit-loss-change https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-realized-gain https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-realized-loss-excluding-other-than-temporary-impairment https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-number-of-positions https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-loss https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-number-of-positions https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-gross-realized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-gross-unrealized-gain-loss https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/mersana-therapeutics-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/mersana-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/mersana-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/mersana-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/mersana-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/mersana-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/mersana-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/mersana-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/mersana-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/mersana-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/mersana-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/mersana-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/mersana-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/mersana-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/mersana-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/mersana-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/mersana-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/mersana-therapeutics-inc/concentration-risk-credit-risk-financial-instrument-maximum-exposure https://stock.noler.com/us/stock/mersana-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/mersana-therapeutics-inc/contract-with-customer-asset-net https://stock.noler.com/us/stock/mersana-therapeutics-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/mersana-therapeutics-inc/contract-with-customer-performance-obligation-satisfied-in-previous-period https://stock.noler.com/us/stock/mersana-therapeutics-inc/contract-with-customer-receivable-after-allowance-for-credit-loss https://stock.noler.com/us/stock/mersana-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/mersana-therapeutics-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/mersana-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/mersana-therapeutics-inc/cumulative-effect-on-retained-earnings-net-of-tax https://stock.noler.com/us/stock/mersana-therapeutics-inc/current-assets https://stock.noler.com/us/stock/mersana-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/mersana-therapeutics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-periodic-payment-principal https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/mersana-therapeutics-inc/debt-unamortized-premium https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-tax-deferred-expense https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-unrealized-losses-on-available-for-sale-gross https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/mersana-therapeutics-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/mersana-therapeutics-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/mersana-therapeutics-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/mersana-therapeutics-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/mersana-therapeutics-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/mersana-therapeutics-inc/deposit-assets https://stock.noler.com/us/stock/mersana-therapeutics-inc/depreciation https://stock.noler.com/us/stock/mersana-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/mersana-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/mersana-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/mersana-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/mersana-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/eps https://stock.noler.com/us/stock/mersana-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/mersana-therapeutics-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/mersana-therapeutics-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/mersana-therapeutics-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-interest-expense https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-right-of-use-asset-accumulated-amortization https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-right-of-use-asset-before-accumulated-amortization https://stock.noler.com/us/stock/mersana-therapeutics-inc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/mersana-therapeutics-inc/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/mersana-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/mersana-therapeutics-inc/form-d-corporate-securities https://stock.noler.com/us/stock/mersana-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/mersana-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/mersana-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/mersana-therapeutics-inc/gain-loss-on-sales-of-assets-and-asset-impairment-charges https://stock.noler.com/us/stock/mersana-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/mersana-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/mersana-therapeutics-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/mersana-therapeutics-inc/income-tax https://stock.noler.com/us/stock/mersana-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/mersana-therapeutics-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/mersana-therapeutics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/mersana-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/mersana-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/mersana-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/mersana-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/mersana-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/mersana-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/mersana-therapeutics-inc/interest-expense-nonoperating https://stock.noler.com/us/stock/mersana-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/mersana-therapeutics-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/mersana-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/mersana-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/mersana-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/mersana-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/mersana-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/mersana-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/mersana-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/mersana-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/mersana-therapeutics-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/mersana-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/mersana-therapeutics-inc/net-income https://stock.noler.com/us/stock/mersana-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/mersana-therapeutics-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/mersana-therapeutics-inc/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/mersana-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/mersana-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/mersana-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/mersana-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/mersana-therapeutics-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/mersana-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/mersana-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/mersana-therapeutics-inc/other-income https://stock.noler.com/us/stock/mersana-therapeutics-inc/other-noncash-income-expense https://stock.noler.com/us/stock/mersana-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/mersana-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/mersana-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/mersana-therapeutics-inc/paid-in-capital-share-based-compensation-employee-stock-purchase-program-requisite-service-period-recognition https://stock.noler.com/us/stock/mersana-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/mersana-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/mersana-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/mersana-therapeutics-inc/participating-securities-distributed-and-undistributed-earnings-loss-basic https://stock.noler.com/us/stock/mersana-therapeutics-inc/payments-for-restructuring https://stock.noler.com/us/stock/mersana-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/mersana-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/mersana-therapeutics-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/mersana-therapeutics-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/mersana-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/mersana-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/mersana-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/mersana-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/mersana-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/mersana-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/mersana-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/mersana-therapeutics-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/mersana-therapeutics-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/mersana-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/mersana-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/mersana-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/mersana-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/mersana-therapeutics-inc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/mersana-therapeutics-inc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-after-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/mersana-therapeutics-inc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-before-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/mersana-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/mersana-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/mersana-therapeutics-inc/public-float https://stock.noler.com/us/stock/mersana-therapeutics-inc/repayments-of-debt https://stock.noler.com/us/stock/mersana-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/mersana-therapeutics-inc/research-and-development-arrangement-contract-to-perform-for-others-costs-incurred-gross https://stock.noler.com/us/stock/mersana-therapeutics-inc/restricted-cash https://stock.noler.com/us/stock/mersana-therapeutics-inc/restricted-cash-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/mersana-therapeutics-inc/restructuring-and-related-cost-cost-incurred-to-date https://stock.noler.com/us/stock/mersana-therapeutics-inc/restructuring-charges https://stock.noler.com/us/stock/mersana-therapeutics-inc/restructuring-reserve https://stock.noler.com/us/stock/mersana-therapeutics-inc/restructuring-reserve-current https://stock.noler.com/us/stock/mersana-therapeutics-inc/restructuring-reserve-translation-and-other-adjustment https://stock.noler.com/us/stock/mersana-therapeutics-inc/retainage-deposit https://stock.noler.com/us/stock/mersana-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/mersana-therapeutics-inc/revenue https://stock.noler.com/us/stock/mersana-therapeutics-inc/revenues https://stock.noler.com/us/stock/mersana-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/mersana-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/mersana-therapeutics-inc/security-deposit https://stock.noler.com/us/stock/mersana-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/mersana-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/mersana-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/mersana-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/mersana-therapeutics-inc/short-term-borrowings https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-redeemed-or-called-value https://stock.noler.com/us/stock/mersana-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/mersana-therapeutics-inc/stockholders-equity-change https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-rate-reconciliation-tax-cuts-and-jobs-act-percent https://stock.noler.com/us/stock/mersana-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/mersana-therapeutics-inc/total-assets https://stock.noler.com/us/stock/mersana-therapeutics-inc/total-contract-liability https://stock.noler.com/us/stock/mersana-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/mersana-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/mersana-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/mersana-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/mersana-therapeutics-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/mersana-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/mersana-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted